Exploring Seaport's IPO and the Ongoing Obesity Pill Debate
In this week's episode of "The Readout LOUD" podcast, we delve into Seaport Therapeutics' IPO success, the competitive landscape of obesity treatments, and the challenges faced by the FDA commissioner.